Open in interactive viewer → charts, metric popovers & call review

Birchtech: A $78 Million Judgment, a $31 Million Market Cap, and a Water Pivot That Arrived as a Terminated Deal

Product revenue grew 15.7% and the balance sheet is debt-free — but the water catalysts management promised for Q3 turned into a scrapped acquisition and a CapEx-free carbon supply contract, and the tape is still pricing the second act at zero.
BCHT · Earnings Call · 2026-11-12

A litigation annuity wearing a growth company's clothes

Birchtech is two businesses stacked on top of each other, and only one of them is currently producing revenue. The first is a patent estate. Its SEA sorbent platform is used in roughly 80% of U.S. coal-fired plants that run sorbent-based mercury control, and management says it has collected approximately $37 million in license fees and settlements since launching enforcement in 2019 — a seven-year slog that lives inside the company as patent enforcement. The crown jewel is a ~$78 million final judgment against the CERT defendants, now on appeal at the Federal Circuit, where Birchtech filed its appellee brief on October 22. “We've asked the Federal Court to affirm the jury's verdict and the approximately $78 million final judgment in full. Just as importantly, the appeal does not stop the clock. Post-judgment interest continues to accrue while the appeal is pending.” — Richard MacPherson, Chief Executive Officer · 2026-11-12 That last sentence matters more than any growth metric on this call. Against a ~$31 million market cap (company_metadata), a $78 million judgment — even one heavily discounted for appellate risk and time — is the entire investment case. The appeal process is now on a short leash: the CEO expects the other side to respond within 30 to 45 days before the matter goes to the court for review. And the balance sheet has been transformed by that program: cash went from $2.2 million at December 31, 2025 to $10.8 million at September 30, 2026, with no debt. The offset is a $7.1 million profit share liability that is nonrecourse and only payable out of litigation proceeds — a footnote that matters enormously if you are underwriting the collection.

The water pivot: promised in August, delivered differently in November

Here is where the story gets interesting, because the prior calls set a very specific expectation and the current one quietly revised it. On the August call, management said of the water business: “I very much expect to bring some hard news to the market most likely in the third quarter” — Richard MacPherson, Chief Executive Officer · 2026-08-13, and on the rejuvenation facility specifically, “I'm hoping most likely sometime by the end of September to be able to bring some material news to the market on that front, which will move us ahead significantly on that side of our business.” — Richard MacPherson, Chief Executive Officer · 2026-08-13 The "material news" that arrived in September was a nonbinding term sheet for an acquisition — which Birchtech then walked away from. What replaced it is a supply agreement with an industry partner for high-grade granular activated carbon: 2,000 tons per year beginning in the first quarter of 2027, scalable to roughly 10,000 tons, with zero capital outlay.

Instead of spending millions of dollars in the acquisition, this is CapEx-free and offers still very strong margins for us as we move forward to represent this manufacturing plant that's just about to come online.

Richard MacPherson, Chief Executive Officer · 2026-11-12
Read charitably, this is a better deal: same market entry, no capital risk, faster. Read skeptically, the company traded an owned asset for a distribution arrangement on someone else's plant, and the thing the market was actually told to wait for — an owned Rejuvenation facility with signed offtake — still does not exist. Management now says it expects announcements on "placement of a facility or 2" with utilities before year-end, on an 18- to 24-month build clock from decision. That is a 2028 revenue event masquerading as a 2026 catalyst. The keyword record tells this story cleanly. In the prior quarter, activated carbon sat atop the company's keyword table as the generic thesis. This quarter it has been displaced by a much more specific, product-level vocabulary: water market, Design Centers, and an explicit focus on smaller systems — the rural and mid-sized utilities that new hire Charlie Cooper was brought in to chase. That is a shift from storytelling to channel-building, which is either maturity or a tell that the big contracts aren't landing.

The numbers underneath the language

Q3 revenue fell to $5.5 million from $7.4 million, but that comparison is a mirage: the prior-year quarter contained a $2.6 million one-time license fee. Product revenue rose 15.7% to $5.5 million, and Birchtech recognized water treatment sales in 2026 versus none a year earlier. SG&A fell 35% to $1.8 million on lower legal fees. What is less flattering is the mix. Gross margin collapsed to 29.9% from 54.8%, and adjusted EBITDA flipped to a $0.5 million loss from a $1.0 million gain. Revenue of $4 million in the latest filed quarter — up 32% year-over-year, but still short of the $9 million quarterly peak set back in 2017 — is the honest shape of the operating business. Which makes the March guidance worth revisiting. On the Q1 call the CEO said: “I do figure that we will be in excess of $20 million on the air side for 2026.” — Richard MacPherson, Chairman and CEO · 2026-03-31 Through three quarters, total revenue is roughly $13.5 million, with the seasonally strong Q3 at $5.5 million. Reaching "in excess of $20 million" would require a Q4 meaningfully above the strongest quarter of the year. That is not a call Birchtech repeated on this call, and the absence is itself informative.

What the tape is saying — and where the confluence cuts both ways

Birchtech's stock is down about 10.6% over 90 days and nearly 50% from its June 2026 peak of $2.34, sitting near $1.2 — a long way from the $15-plus of 2012 and even from the price at which management began buying. In mid-September the company started purchasing under a $5 million authorization, buying 103,864 shares at an average of $1.64. That is roughly 3% of the program and — given the subsequent drift — a purchase made into a falling tape. Management's view that the shares are undervalued is a statement of faith in the judgment and the water ramp; the market's counter is a price-to-revenue multiple of 2.7x, down 81% year-over-year from an already-depressed base. Nobody is paying for optionality here. There are two genuine macro tailwinds. The first is the broader water treatment build-out — the market's own curated vocabulary for this quarter includes Water Solutions as a rising theme, and the federal PFAS limits of 4 parts per trillion remain in place even as the EPA dangles compliance extensions. The second is coal fired generation, where Birchtech argues data-center and AI electricity demand is extending the operating runway for the very plants that buy its sorbent. That is a real, articulable link between a hot market theme and a distinctly un-hot business. “We've got about an 18- to 24-month ramp-up from time of decision to go forward to have that plant online.” — Richard MacPherson, Chief Executive Officer · 2026-11-12 That single sentence is the honest timeline for the entire water thesis, and it is why the stock is not moving on water news. Birchtech is a $31 million company with $10.8 million of cash, a possible $78 million receivable, a buyback it has barely used, and a water business whose first meaningful revenue is a 2027 supply contract. The next four catalysts are: an appellate ruling, a collection event, first carbon shipments in Q1 2027, and a facility placement announcement that has slipped once already. Everything else on this call was housekeeping.